Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-™T) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer

1 day ago 4

1. Homepage
2. Finance
3. Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-™T) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer